Introduction to pharmaceutical industry & clinical research
Bio-IT Workshop: Positioning Your Firm. January 21, 2003 Understanding the Intersection Between Information Technology and the Life Sciences The Terrain.
Writing Good Training Material Objectives By Sylvia A. Miller Senior Consultant Spherion and Mindy Hoffbauer Training, Testing & Technical Documentation.
EBM Chengyu (Cheryl) Xu March, 2012 ACS trials. Outline – over 70 ACS trials Mangement strategy Cardiogenic shock Lytics/Referfusion Stable CAD/Elective.
Introduction Charles B. Hicks, MD Professor of Medicine Associate Director, Duke AIDS Research and Treatment Center Duke University Medical Center Durham,
Technological Innovation and Intellectual Capital BUA5FTS – WEEK 1.
James W. Cooper, RPh,PhD, BCPS, CGP, FASCP, FASHP, FCP, Emeritus Professor of Pharmacy, UGa and Consultant Pharmacist NOTE: Dr.J. Russell May of GHSU and.
The Evolving Science and Controversial Landscape of Antiplatelet Therapy in the Catheterization Laboratory Mechanisms Mortality Therapeutics PROGRAM CO-CHAIRMAN.
Landmark Practice Advances In ST-Elevation Myocardial Infarction (STEMI) and Acute Coronary Syndrome (ACS) Consistent and Unified Management Strategies.
New Frontiers and Advances in Oral Therapy for Type 2 Diabetes Focus on DPP-4 Inhibition and Incretin-Based Therapy (IBT) Program Chairman Charles Faiman,
I-PRESERVE Trial Irbesartan in heart failure with preserved EF Co-PIs: Peter Carson and Barry Massie Executive Committee M. Komajda, R. McKelvie, J. McMurray,
Welcome! The Peer Review Process: What Happens After the Exit Briefing? Kathryn Bayne, MS, PhD, DVM, DACLAM, CAAB, Senior Director and Director of Pacific.